Lifecore Biomedical, Inc. De DEFM14A, filed Nov 13, 2026
Lifecore Biomedical, Inc. De (LFCR)
Lifecore Biomedical stockholders will vote on December 23, 2026 on a merger that would make the company a wholly owned subsidiary, paying $6.28 per common share in cash plus one contingent value right. AI summary
DEFM14A
2026-11-13
View Original
Added on
November 13, 2026